Rb+ efflux through functional activation of cardiac KCNQ1/minK channels by the benzodiazepine R-L3 (L-364,373).

The slow delayed rectifier K+ current, Iks, encoded by KCNQ1 (KvLQT1)/KCNE1 (mink) genes, contributes to cardiac action potential repolarization and determines the heartbeat rate. Mutations in either KCNQ1 or KCNE1 that reduce Iks cause long-QT syndrome (LQTS), a disorder of ventricular repolarization that results in cardiac arrhythmia and sudden death. A well-recognized potential treatment for LQTS caused by reduction of Iks is to enhance functional activation of cardiac KCNQ1/KCNE1 channels. In the present study, we generated a stable Chinese hamster ovary cell line that expresses KCNQ1/KCNE1 channels confirmed by electrophysiology. Using a pharmacological tool compound R-L3 (L-364,373 [(3-R)-1,3-dihydro-5-(2-fluorophenyl)-3-(1H-indol- 3-ylmethyl)-1-methyl-2H-1,4-benzodiazepin-2-one]), which activates KCNQ1/mink channels, we then developed and validated a non-radioactive rubidium (Rb+) efflux assay that directly measures the functional activity of KCNQ1/KCNE1 channels by atomic absorption spectroscopy. Our results show that the validated Rb+ efflux assay can be used for screening of KCNQ1/KCNE1 openers that potentially treat LQTS in both inherited and acquired forms. In addition, the assay also can be used for evaluation of possible long-QT liability during cardiac selectivity of new chemical entities.

[1]  Kewei Wang,et al.  Validation of an atomic absorption rubidium ion efflux assay for KCNQ/M-channels using the ion Channel Reader 8000. , 2004, Assay and drug development technologies.

[2]  M. Sanguinetti,et al.  Pharmacological Activation of Normal and Arrhythmia-Associated Mutant KCNQ1 Potassium Channels , 2003, Circulation research.

[3]  Clay W Scott,et al.  A medium-throughput functional assay of KCNQ2 potassium channels using rubidium efflux and atomic absorption spectrometry. , 2003, Analytical biochemistry.

[4]  P. Kowey,et al.  Increasing I(Ks) corrects abnormal repolarization in rabbit models of acquired LQT2 and ventricular hypertrophy. , 2002, American journal of physiology. Heart and circulatory physiology.

[5]  D. Mckinnon,et al.  Molecular basis for differential sensitivity of KCNQ and I(Ks) channels to the cognitive enhancer XE991. , 2000, Molecular pharmacology.

[6]  D. A. Brown,et al.  Differential tetraethylammonium sensitivity of KCNQ1–4 potassium channels , 2000, British journal of pharmacology.

[7]  B. Attali,et al.  Stilbenes and fenamates rescue the loss of IKS channel function induced by an LQT5 mutation and other IsK mutants , 1999, The EMBO journal.

[8]  G. Terstappen,et al.  Functional analysis of native and recombinant ion channels using a high-capacity nonradioactive rubidium efflux assay. , 1999, Analytical biochemistry.

[9]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[10]  B S Brown,et al.  KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. , 1998, Science.

[11]  M. Sanguinetti,et al.  A novel benzodiazepine that activates cardiac slow delayed rectifier K+ currents. , 1998, Molecular pharmacology.

[12]  R. Jongbloed,et al.  The long QT syndrome: a novel missense mutation in the S6 region of the KVLQT1 gene , 1997, Human Genetics.

[13]  Jacques Barhanin,et al.  KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium current , 1996, Nature.

[14]  M. Sanguinetti,et al.  Coassembly of KVLQT1 and minK (IsK) proteins to form cardiac IKS potassium channel , 1996, Nature.

[15]  P. Brink,et al.  Evidence of a long QT founder gene with varying phenotypic expression in South African families. , 1996, Journal of medical genetics.

[16]  S. Goldstein,et al.  Subunit composition of mink potassium channels , 1995, Neuron.